FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$439M
This Quarter Return
-9.85%
1 Year Return
+25.58%
3 Year Return
+78.33%
5 Year Return
+134.68%
10 Year Return
+224.6%
AUM
$496M
AUM Growth
+$496M
(-15%)
Cap. Flow
-$29.4M
Cap. Flow
% of AUM
-5.93%
Top 10 Holdings %
Top 10 Hldgs %
53.18%
Holding
63
New
5
Increased
14
Reduced
30
Closed
4
Top Buys
| 1 |
Sanofi
SNY
|
$4.31M |
| 2 |
Linde
LIN
|
$3.28M |
| 3 |
Copart
CPRT
|
$1.69M |
| 4 |
Valvoline
VVV
|
$1.51M |
| 5 |
Marsh & McLennan
MMC
|
$1.34M |
Top Sells
| 1 |
L3Harris
LHX
|
$7.35M |
| 2 |
Medtronic
MDT
|
$6.43M |
| 3 |
Union Pacific
UNP
|
$5.2M |
| 4 |
PX
Praxair Inc
PX
|
$3.81M |
| 5 |
Emerson Electric
EMR
|
$2.77M |
Sector Composition
| 1 | Healthcare | 35.16% |
| 2 | Technology | 18.59% |
| 3 | Financials | 12.44% |
| 4 | Industrials | 12.37% |
| 5 | Consumer Staples | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
| $44.2M | 8.91% | 647,346 -37,508 | -5% | -$2.56M |
|
|
2
Medtronic
MDT
$119B
| $37.6M | 7.57% | 413,288 -70,645 | -15% | -$6.43M |
|
3
Johnson & Johnson
JNJ
$427B
| $34M | 6.86% | 263,716 +8,466 | +3% | +$1.09M |
|
4
Microsoft
MSFT
$3.77T
| $31M | 6.25% | 305,309 -1,929 | -0.6% | -$196K |
|
5
RTX Corp
RTX
$212B
| $21.6M | 4.36% | 203,248 +957 | +0.5% | +$102K |
|
6
PepsiCo
PEP
$204B
| $20.7M | 4.17% | 187,168 -6,746 | -3% | -$745K |
|
7
UnitedHealth
UNH
$281B
| $19.8M | 3.98% | 79,385 -1,563 | -2% | -$389K |
|
8
Cisco
CSCO
$274B
| $18.8M | 3.8% | 435,021 +6,561 | +2% | +$284K |
|
9
American Express
AXP
$231B
| $18.3M | 3.68% | 191,747 -1,314 | -0.7% | -$125K |
|
10
Aon
AON
$79.1B
| $17.9M | 3.6% | 122,979 -3,353 | -3% | -$487K |
|
|
11
Valvoline
VVV
$4.93B
| $16.6M | 3.35% | 859,641 +77,846 | +10% | +$1.51M |
|
12
Motorola Solutions
MSI
$78.7B
| $16.1M | 3.23% | 139,540 -14,710 | -10% | -$1.69M |
|
|
13
Union Pacific
UNP
$133B
| $15.9M | 3.21% | 115,270 -37,626 | -25% | -$5.2M |
|
14
Philip Morris
PM
$260B
| $14.9M | 3% | 223,221 +12,171 | +6% | +$813K |
|
15
Oracle
ORCL
$635B
| $12.6M | 2.53% | 278,152 -15,853 | -5% | -$716K |
|
16
Pfizer
PFE
$141B
| $11.7M | 2.36% | 268,067 -22,283 | -8% | -$973K |
|
17
Truist Financial
TFC
$60.4B
| $10.7M | 2.16% | 247,966 +14,082 | +6% | +$610K |
|
18
Wells Fargo
WFC
$263B
| $10.2M | 2.05% | 220,869 -15,538 | -7% | -$716K |
|
19
Baxter International
BAX
$12.7B
| $9.64M | 1.94% | 146,402 -32,837 | -18% | -$2.16M |
|
20
C.H. Robinson
CHRW
$15.2B
| $7.55M | 1.52% | 89,744 -7,930 | -8% | -$667K |
|
21
Gentex
GNTX
$6.15B
| $7.37M | 1.49% | 364,887 -122,236 | -25% | -$2.47M |
|
22
Novartis
NVS
$245B
| $6.91M | 1.39% | 80,575 -7,046 | -8% | -$605K |
|
23
Sabre
SABR
$706M
| $5.95M | 1.2% | 274,864 -20,065 | -7% | -$434K |
|
24
Hershey
HSY
$37.3B
| $5.79M | 1.17% | 53,975 -12,687 | -19% | -$1.36M |
|
25
W.W. Grainger
GWW
$48.5B
| $5.76M | 1.16% | 20,401 -1,593 | -7% | -$450K |
|